Incorporating Supersaturated Oxygen in Shock

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 17, 2021

Primary Completion Date

January 17, 2024

Study Completion Date

June 30, 2025

Conditions
Cardiogenic ShockSTEMI
Interventions
DEVICE

SSO2 Downstream System

60-min adjunctive reperfusion of hyperoxemic blood into target coronary artery, immediately following revascularization by means of PCI with stenting.

PROCEDURE

PCI + Impella

Standard of Care Intervention

Trial Locations (7)

15212

Allegheny General Hospital, Pittsburgh

18103

Lehigh Valley Hospital-Cedar Crest, Allentown

27610

WakeMed, Raleigh

29605

Prisma Health Greenville Memorial Hospital, Greenville

33176

Baptist Health South Florida, Miami

48202

Henry Ford Health System, Detroit

01199

Baystate Medical Center, Springfield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TherOx

INDUSTRY

NCT04876040 - Incorporating Supersaturated Oxygen in Shock | Biotech Hunter | Biotech Hunter